Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood

Journal of Lipid Research

Volumn 44, Issue 4, 2003, Pages 859-865

  Gälman, Cecilia ^a   Arvidsson, Ingela ^a   Angelin, Bo ^a   Rudling, Mats ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholestyramine; Cholic acid; CYP7A1; High performance liquid chromatography; Species

Indexed keywords

7ALPHA HYDROXYCHOLEST 4 EN 3 ONE; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL DERIVATIVE; CHOLIC ACID; COLESTYRAMINE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BILE ACID SYNTHESIS; BLOOD; CHOLESTEROL METABOLISM; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; LIVER; MALE; MONITORING; NONHUMAN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; RAT; SERUM; SPECIES DIFFERENCE;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTENONES; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; HUMANS; LIVER; MALE; METHODS; RATS; RATS, WISTAR;

EID: 0142074212     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.D200043-JLR200     Document Type: Article

References (39)

1. Russell, D. W., and K. D. Setchell. 1992. Bile acid biosynthesis. Biochemistry. 31: 4737-4749.
2. Angelin, B. 1995. 1994 Mack-Forster Award Lecture. Review. Studies on the regulation of hepatic cholesterol metabolism in humans. Eur. J. Clin. Invest. 26: 215-224.
3. Dietschy, J. M., S. D. Turley, and D. K. Spady. 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34: 1637-1659.
4. Levine, G. N., J. F. Keaney, Jr., and J. A. Vita. 1995. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N. Engl. J. Med. 332: 512-521.
5. Axelson, M., and J. Sjovall. 1990. Potential bile acid precursors in plasma-possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man. J. Steroid Biochem. 36: 631-640.
6. Shefer, S., S. Hauser, I. Bekersky, and E. H. Mosbach. 1970. Biochemical site of regulation of bile acid biosynthesis in the rat. J. Lipid Res. II: 404-411.
7. Bjorkhem, I., and G. Eggertsen. 2001. Genes involved in initial steps of bile acid synthesis. Curr. Opin. Lipidol. 12: 97-103.
8. Schwarz, M., D. W. Russell, J. M. Dietschy, and S. D. Turley. 2001. Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. J. Lipid Res. 42: 1594-1603.
9. Bjorkhem, I., Z. Araya, M. Rudling, B. Angelin, C. Einarsson, and K. Wikvall. 2002. Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J. Biol. Chem. 277: 26804-26807.
10. Rudling, M., B. Angelin, L. Stahle, E. Reihner, S. Sahlin, H. Olivecrona, I. Bjorkhem, and C. Einarsson. 2002. Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver. J. Clin. Endocrinol. Metab. 87: 4307-4313.
11. Akerlund, J. E., E. Reihner, B. Angelin, M. Rudling, S. Ewerth, I. Bjorkhem, and K. Einarsson. 1991. Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. Gastroenterology. 100: 1046-1053.
12. Reihner, E., B. Angelin, M. Rudling, S. Ewerth, I. Bjorkhem, and K. Einarsson. 1990. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J. Lipid Res. 31: 2219-2226.
13. Root, C., C. D. Smith, S. S. Sundseth, H. M. Pink, J. G. Wilson, and M. C. Lewis. 2002. Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94. J. Lipid Res. 43: 1320-1330.
14. Ichihashi, T., M. Izawa, K. Miyata, T. Mizui, K. Hirano, and Y. Takagishi. 1998. Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption. J. Pharmacol. Exp. Ther. 284: 43-50.
15. Gälman, C., A-M. Östlund-Lindqvist, A. Björquist, S. Schreyer, L. Svensson, B. Angelin, and M. Rudling. 2003. Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency. FASEB J. 17: 265-267.
16. Urizar, N. L., A. B. Liverman, D. T. Dodds, F. V. Silva, P. Ordentlich, Y. Yan, F. J. Gonzalez, R. A. Heyman, D. J. Mangelsdorf, and D. D. Moore. 2002. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 296: 1703-1706.
17. Rudling, M., and B. Angelin. 2001. Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice. FASEB J. 15: 1350-1356.
18. Kekki, M., T. A. Miettinen, and B. Wahlstrom. 1977. Measurement of cholesterol synthesis in kinetically defined pools using fecal steroid analysis and double labeling technique in man. J. Lipid Res. 18: 99-114.
19. Lindstedt, S. 1957. Turnover of cholic acid in man. Acta Physiol. Scand. 40: 1-7.
20. Axelson, M., A. Aly, and J. Sjovall. 1988. Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett. 239: 324-328.
21. Axelson, M., I. Bjorkhem, E. Reihner, and K. Einarsson. 1991. The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man. FEBS Lett. 284: 216-218.
22. Sauter, G., F. Berr, U. Beuers, S. Fischer, and G. Paumgartner. 1996. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology. 24: 123-126.
23. Gullberg, H., M. Rudling, D. Forrest, B. Angelin, and B. Vennstrom. 2000. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol. Endocrinol. 14: 1739-1749.
24. Aringer, L., and L. Nordstrom. 1981. Side-chain oxidation of mono-oxygenated C27- and C29-steroids in rat liver mitochondria and 18000 x g supernatant. Biochim. Biophys. Acta. 665: 13-21.
25. Einarsson, K., B. Angelin, S. Ewerth, K. Nilsell, and I. Bjorkhem. 1986. Bile acid synthesis in man: assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by isotope dilution-mass spectrometry. J. Lipid Res. 27: 82-88.
26. Sundseth, S. S., and D. J. Waxman. 1990. Hepatic P-450 cholesterol 7 alpha-hydroxylase. Regulation in vivo at the protein and mRNA level in response to mevalonate, diurnal rhythm, and bile acid feedback. J. Biol. Chem. 265: 15090-15095.
27. Pettersson, L., and C. G. Eriksson. 1994. Reversed-phase high-performance liquid chromatographic determination of 7 alpha-hydroxy-4-cholesten-3-one in human serum. J. Chromatogr. B Biomed. Appl. 657: 31-36.
28. Sauter, G. H., W. Munzing, C. von Ritter, and G. Paumgartner. 1999. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig. Dis. Sci. 44: 14-19.
29. Eusufzai, S., M. Axelson, B. Angelin, and K. Einarsson. 1993. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut. 34: 698-701.
30. Brydon, W. G., H. Nyhlin, M. A. Eastwood, and M. V. Merrick. 1996. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur. J. Gastroenterol. Hepatol. 8: 117-123.
31. Rust, C., G. H. Sauter, M. Oswald, J. Buttner, G. A. Kullak-Ublick, G. Paumgartner, and U. Beuers. 2000. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. Eur. J. Clin. Invest. 30: 135-139.
32. Muhrbeck, O., F. H. Wang, I. Bjorkhem, M. Axelson, and K. Einarsson. 1997. Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects. J. Hepatol. 27: 150-155.
33. Parini, P., B. Angelin, and M. Rudling. 1999. Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler. Thromb. Vasc. Biol. 19: 832-839.
34. Rudling, M., and B. Angelin. 1993. Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J. Clin. Invest. 91: 2796-2805.
35. Rudling, M., P. Parini, and B. Angelin. 1997. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J. Clin. Invest. 99: 2239-2245.
36. Stahlberg, D., E. Reihner, M. Rudling, L. Berglund, K. Einarsson, and B. Angelin. 1995. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology. 21: 1025-1030.
37. Reihner, E., B. Angelin, I. Bjorkhem, and K. Einarsson. 1991. Hepatic cholesterol metabolism in cholesterol gallstone disease. J. Lipid Res. 32: 469-475.
38. Stahlberg, D., M. Rudling, B. Angelin, I. Bjorkhem, P. Forsell, K. Nilsell, and K. Einarsson. 1997. Hepatic cholesterol metabolism in human obesity. Hepatology. 25: 1447-1450.
39. Nguyen, L. B., S. Shefer, G. Salen, J. Y. Chiang, and M. Patel. 1996. Cholesterol 7alpha-hydroxylase activities from human and rat liver are modulated in vitro posttranslationally by phosphorylation/dephosphorylation. Hepatology. 24: 1468-1474.